Lupin Completes VISUfarma Acquisition, Expands European Ophthalmology Portfolio Across Key Markets
Published on: April 2, 2026, 11:38 a.m. | Source: Free Press Journal
Lupin Limited has completed the acquisition of VISUfarma B.V., a European specialty pharmaceutical company focused on ophthalmology. The deal expands Lupin’s portfolio to over 60 eye care products. VISUfarma, which generated 53 million euros in revenue in 2025, adds commercial scale and expertise, supporting Lupin’s strategy to grow its specialty care business.
